17-79779446-C-CTG
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_005189.3(CBX2):c.182+20_182+21dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,608,050 control chromosomes in the GnomAD database, including 61,198 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.28 ( 5986 hom., cov: 21)
Exomes 𝑓: 0.27 ( 55212 hom. )
Consequence
CBX2
NM_005189.3 intron
NM_005189.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.47
Genes affected
CBX2 (HGNC:1552): (chromobox 2) This gene encodes a component of the polycomb multiprotein complex, which is required to maintain the transcriptionally repressive state of many genes throughout development via chromatin remodeling and modification of histones. Disruption of this gene in mice results in male-to-female gonadal sex reversal. Mutations in this gene are also associated with gonadal dysgenesis in humans. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 17-79779446-C-CTG is Benign according to our data. Variant chr17-79779446-C-CTG is described in ClinVar as [Benign]. Clinvar id is 1601133.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CBX2 | NM_005189.3 | c.182+20_182+21dup | intron_variant | ENST00000310942.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CBX2 | ENST00000310942.9 | c.182+20_182+21dup | intron_variant | 1 | NM_005189.3 | P1 | |||
CBX2 | ENST00000269399.5 | c.182+20_182+21dup | intron_variant | 1 | |||||
CBX2 | ENST00000571484.1 | n.275_276dup | non_coding_transcript_exon_variant | 3/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.276 AC: 41901AN: 151736Hom.: 5984 Cov.: 21
GnomAD3 genomes
AF:
AC:
41901
AN:
151736
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.248 AC: 61273AN: 247204Hom.: 8141 AF XY: 0.255 AC XY: 34253AN XY: 134074
GnomAD3 exomes
AF:
AC:
61273
AN:
247204
Hom.:
AF XY:
AC XY:
34253
AN XY:
134074
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.271 AC: 394410AN: 1456196Hom.: 55212 Cov.: 30 AF XY: 0.272 AC XY: 197385AN XY: 724550
GnomAD4 exome
AF:
AC:
394410
AN:
1456196
Hom.:
Cov.:
30
AF XY:
AC XY:
197385
AN XY:
724550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.276 AC: 41924AN: 151854Hom.: 5986 Cov.: 21 AF XY: 0.271 AC XY: 20087AN XY: 74198
GnomAD4 genome
AF:
AC:
41924
AN:
151854
Hom.:
Cov.:
21
AF XY:
AC XY:
20087
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
783
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at